TR200200449T2 - Klonidin içeren etken madde kombinasyonu - Google Patents

Klonidin içeren etken madde kombinasyonu

Info

Publication number
TR200200449T2
TR200200449T2 TR2002/00449T TR200200449T TR200200449T2 TR 200200449 T2 TR200200449 T2 TR 200200449T2 TR 2002/00449 T TR2002/00449 T TR 2002/00449T TR 200200449 T TR200200449 T TR 200200449T TR 200200449 T2 TR200200449 T2 TR 200200449T2
Authority
TR
Turkey
Prior art keywords
active ingredient
combination containing
ingredient combination
containing clonidine
clonidine
Prior art date
Application number
TR2002/00449T
Other languages
English (en)
Inventor
Brecht Hans-Michael
Original Assignee
Boehringer Ingelhheim Pharma Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelhheim Pharma Kg filed Critical Boehringer Ingelhheim Pharma Kg
Publication of TR200200449T2 publication Critical patent/TR200200449T2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4168—1,3-Diazoles having a nitrogen attached in position 2, e.g. clonidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Mevcut bulus klonidin ve pramipeksol'den olusan ve Restless Leg sendromunun tedavisine yönelik bir etken madde kombinasyonu ile ilgilidir.
TR2002/00449T 1999-08-19 2000-08-09 Klonidin içeren etken madde kombinasyonu TR200200449T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19938825A DE19938825A1 (de) 1999-08-19 1999-08-19 Wirkstoffkombination mit Clonidin

Publications (1)

Publication Number Publication Date
TR200200449T2 true TR200200449T2 (tr) 2002-08-21

Family

ID=7918574

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2002/00449T TR200200449T2 (tr) 1999-08-19 2000-08-09 Klonidin içeren etken madde kombinasyonu

Country Status (19)

Country Link
US (1) US20020010201A1 (tr)
EP (1) EP1210081A2 (tr)
JP (1) JP2003507420A (tr)
KR (1) KR20020060163A (tr)
AR (1) AR025330A1 (tr)
AU (1) AU6440600A (tr)
BR (1) BR0013353A (tr)
CA (1) CA2376606A1 (tr)
CO (1) CO5200840A1 (tr)
CZ (1) CZ2002515A3 (tr)
DE (1) DE19938825A1 (tr)
IL (1) IL147741A0 (tr)
MX (1) MXPA02001138A (tr)
NO (1) NO20020793L (tr)
PE (1) PE20010642A1 (tr)
PL (1) PL353358A1 (tr)
TR (1) TR200200449T2 (tr)
UY (1) UY26293A1 (tr)
WO (1) WO2001013902A2 (tr)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10041478A1 (de) * 2000-08-24 2002-03-14 Sanol Arznei Schwarz Gmbh Neue pharmazeutische Zusammensetzung
ES2432527T3 (es) 2001-12-11 2013-12-04 University Of Virginia Patent Foundation Uso de pramipexol para tratar la esclerosis lateral amiotrófica
DE10220230A1 (de) * 2002-05-06 2003-11-27 Sanol Arznei Schwarz Gmbh Verwendung von Rotigotine zur Behandlung des Restless Leg Syndroms
US20040048779A1 (en) * 2002-05-06 2004-03-11 Erwin Schollmayer Use of rotigotine for treating the restless leg syndrome
CN1671390A (zh) 2002-08-30 2005-09-21 协和发酵工业株式会社 用于治疗多动腿综合症或相关疾病的腺苷a2a受体拮抗剂
EP1426049B1 (en) * 2002-12-02 2005-05-18 Schwarz Pharma Ag Iontophoretic delivery of rotigotine for the treatment of Parkinson's disease
US8518926B2 (en) 2006-04-10 2013-08-27 Knopp Neurosciences, Inc. Compositions and methods of using (R)-pramipexole
DK2026803T3 (da) 2006-05-16 2012-04-16 Knopp Neurosciences Inc Sammensætninger af R(+) og S(-) pramipexol og fremgangsmåder til anvendelse heraf
WO2008009664A2 (en) * 2006-07-19 2008-01-24 Boehringer Ingelheim International Gmbh Treatment of pain
US8524695B2 (en) 2006-12-14 2013-09-03 Knopp Neurosciences, Inc. Modified release formulations of (6R)-4,5,6,7-tetrahydro-N6-propyl-2,6-benzothiazole-diamine and methods of using the same
AU2008224844B2 (en) 2007-03-14 2012-08-09 Knopp Neurosciences, Inc. Synthesis of chirally purified substituted benzothiazole diamines
EP1987815A1 (en) * 2007-05-04 2008-11-05 Schwarz Pharma Ag Oronasopharyngeally deliverable pharmaceutical compositions of dopamine agonists for the prevention and/or treatment of restless limb disorders
CN102186350A (zh) 2008-08-19 2011-09-14 诺普神经科学股份有限公司 使用(r)-普拉克索的组合物与方法
US9512096B2 (en) 2011-12-22 2016-12-06 Knopp Biosciences, LLP Synthesis of amine substituted 4,5,6,7-tetrahydrobenzothiazole compounds
US20150342899A1 (en) * 2012-12-28 2015-12-03 Noven Pharmaceuticals, Inc. Compositions and methods for transdermal delivery of amphetamine and clonidine
US9662313B2 (en) 2013-02-28 2017-05-30 Knopp Biosciences Llc Compositions and methods for treating amyotrophic lateral sclerosis in responders
US9468630B2 (en) 2013-07-12 2016-10-18 Knopp Biosciences Llc Compositions and methods for treating conditions related to increased eosinophils
ES2858500T3 (es) 2013-07-12 2021-09-30 Knopp Biosciences Llc Tratamiento de niveles elevados de eosinófilos y/o basófilos
AU2014306683B2 (en) 2013-08-13 2017-10-12 Knopp Biosciences Llc Compositions and methods for treating plasma cell disorders and B-cell prolymphocytic disorders
HUE055850T2 (hu) 2013-08-13 2022-01-28 Knopp Biosciences Llc Készítmények és módszerek a krónikus urticaria (csalánkiütés) kezelésére

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3937271A1 (de) * 1989-11-09 1991-05-16 Boehringer Ingelheim Kg Transdermale applikation von 2-amino-6-n-propylamino-4,5,6,7-tetrahydrobenzothiazol
DE4325491A1 (de) * 1993-07-29 1995-02-02 Boehringer Ingelheim Kg Verwendung von zentral wirksamen alpha-2-Agonisten zur Hemmung des Postaggressionsstoffwechsels
US6001861A (en) * 1998-01-16 1999-12-14 Pharmacia & Upjohn Company Use of pramipexole in the treatment of restless legs syndrome
DE19701619B4 (de) * 1997-01-17 2007-10-11 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verwendung von Pramipexol zur Behandlung des restless legs syndroms
WO2000054773A1 (en) * 1999-03-12 2000-09-21 Nitromed, Inc. Dopamine agonists in combination with nitric oxide donors, compositions and methods of use

Also Published As

Publication number Publication date
AR025330A1 (es) 2002-11-20
PE20010642A1 (es) 2001-06-08
CZ2002515A3 (cs) 2002-05-15
NO20020793D0 (no) 2002-02-18
WO2001013902A2 (de) 2001-03-01
WO2001013902A3 (de) 2001-08-23
CA2376606A1 (en) 2001-03-01
JP2003507420A (ja) 2003-02-25
AU6440600A (en) 2001-03-19
US20020010201A1 (en) 2002-01-24
MXPA02001138A (es) 2002-10-31
DE19938825A1 (de) 2001-04-26
NO20020793L (no) 2002-02-18
CO5200840A1 (es) 2002-09-27
IL147741A0 (en) 2002-08-14
PL353358A1 (en) 2003-11-17
EP1210081A2 (de) 2002-06-05
BR0013353A (pt) 2002-04-23
UY26293A1 (es) 2001-04-30
KR20020060163A (ko) 2002-07-16

Similar Documents

Publication Publication Date Title
TR200200449T2 (tr) Klonidin içeren etken madde kombinasyonu
TR200000059T2 (tr) Piridin türevleri
TR199800697T2 (tr) Farmasötik olarak aktif kinazolin bilesimleri.
ATE346039T1 (de) Sulfonamido-substituierte verbrückte bicycloalkylderivative
HUP0303037A2 (hu) Alzheimer-kór kezelésére alkalmas vegyületek és ezeket tartalmazó gyógyszerkészítmények
FR2757520B1 (fr) Derive de cyclosporine, sa preparation et les compositions pharmaceutiques qui le contiennent
UY26082A1 (es) Derivados de 1,4-diazabiciclo [3.2.2] nonan-4-carboxilato y -carboxamidas, su preparacion y su aplicacion en terapeutica
ATE342728T1 (de) Zubereitung zur behandlung von einer neurologischen erkrankung
DE69400799D1 (de) Verwendung von riluzol zur behandlung von parkinson und den parkinson-syndromen
DE69925133D1 (de) Pyrrolobenzodiazepine
DE60112055D1 (de) Inhibitoren von gamma-secretase
ATE211384T1 (de) Verwendung von adenosinantagonisten zur vorbeugung und behandlung von pankreatitis und ulcera
ATE147981T1 (de) Verabreichung von lamotrigin zur behandlung von neuro-aids
ATE310738T1 (de) Gesättigte 1,2-dithiaheterocyclische verbindungen enthaltende antivirale pharmazeutische zubereitungen
YU47116B (sh) Postupak za dobijanje novih n-supstituisanih benzimidazolskih derivata
DE59813162D1 (de) Pharmazeutische zusammensetzung enthaltend clindamycin und clotrimazol, zur behandlung vaginaler infektionen
BG106155A (en) Novel derivatives and analogues of galanthamin
DE60013486D1 (de) Verbindungen
EE200100188A (et) Optiliselt aktiivne püridüül-4H-1,2,4-oksadiasiini derivaat ja selle kasutamine vaskulaarsete haiguste ravis
CY1111900T1 (el) Θεραπεια του νευροπαθητικου πονου με ανταγωνιστες υποδοχεα ν-μεθυλ-d-ασπαρτικων (nmda)
NO993360D0 (no) Anvendelse av pramipeksol ved behandling av "restless leg"- syndromet
DE3778642D1 (de) Therapeutikum zur behandlung von magengeschwueren.
PT1189615E (pt) Combinacao sinergica endoparasiticida contendo depsipeptideos ciclicos e piperazinas
EA199700032A1 (ru) Дезинфицирующий состав "велтолен"
TR200200111T2 (tr) Neoplazmalar için terapötik ve profilaktik maddeler